Please login to the form below

Not currently logged in
Email:
Password:

trial transparency

This page shows the latest trial transparency news and features for those working in and with pharma, biotech and healthcare.

UCB launches online clinical trial tool

UCB launches online clinical trial tool

Although UCB signed up to a clinical trial data sharing portal in 2014 it only received a mid-table ranking from an AllTrials audit last year. ... Industry-wide pressure from the campaigning group is set to be increased following the drive to name trial

Latest news

  • AllTrials tracker site names clinical trial non-reporters AllTrials tracker site names clinical trial non-reporters

    fine trial sponsors up to $10, 000 per day who fail to publish results “there are, though, trials on that register whose results are years overdue, and to date you have

  • Shire says all its studies will publish in open access journals Shire says all its studies will publish in open access journals

    The new policy comes against a backdrop of a lot of promises by the pharma industry to improve on transparency that have often fallen short. ... Last year for example, an audit of 42 top manufacturers from the EU, US and Japan by the trial transparency

  • The state of trust The state of trust

    The campaign group has been at the forefront of efforts to increase clinical trial transparency - through open publication - and a year ago revealed that around half of all trials run by ... We have been in conversation with AllTrials to make sure that

  • Nearly half of all clinical trials not published Nearly half of all clinical trials not published

    Around half of all trials run by pharma companies, universities and other major research sponsors remain unpublished, according to a tool built to promote greater trial transparency. ... campaign for clinical trial transparency.

  • ABPI says UK role as clinical trial hub threatened by Brexit ABPI says UK role as clinical trial hub threatened by Brexit

    Moreover, patients in the UK would be denied inclusion in a centralised gateway for clinical trial applications - due to be implemented as a result of reforms to EU clinical testing regulations - ... clinical trial applications, greater collaboration

More from news
Approximately 3 fully matching, plus 72 partially matching documents found.

Latest Intelligence

  • LEO: Patients benefit from transparency LEO: Patients benefit from transparency

    LEO’s VP for Europe North Geraldine Murphy (pictured above) sat down with PME to talk about trial transparency and why opening up is so important. ... Every company has their own policies regarding trial transparency, but we need to begin to learn to

  • Interview: Beate Wieseler, IQWIG Interview: Beate Wieseler, IQWIG

    That is still open.”. IQWiG and clinical trial transparency. In addition to its role in German drug pricing, IQWiG has also emerged as one of the leading organisations in the campaign ... for greater transparency of clinical trial detail, becoming one

  • VIDEO interview: Neil Weir, UCB VIDEO interview: Neil Weir, UCB

    Issue of transparency. It's a similar story when it comes to pharma's hot topic of the past 12 months – transparency of clinical trial data. ... on transparency as part of his role on EFPIA's research directors group.

  • Clinical trial regulation in Mexico Clinical trial regulation in Mexico

    private hospital and trial centres can be found concentrated in large urban areas. ... Moreover, training for clinical trial personnel, eg managers and coordinators, is also improving.

More from intelligence
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Sanofi CEO Viehbacher to head EFPIA Sanofi CEO Viehbacher to head EFPIA

    One of the most pressing matters for EFPIA is the seemingly inevitable trend towards transparency of trial data, and Viehbacher has already commented on the subject.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • New ICMJE Guidelines and their Impact on Biotech

    Failure to do so will prevent the reporting of trial results in an ICMJE member journal, and probably many other journals that adhere to ICMJE guidelines. ... While the goal of ICMJE of increasing transparency in the reporting of clinical trial data is

  • Pharma as change champions

    Lack of transparency and clarity in clinical trial data has led, often, to a lack of trust of pharma brands. ... This arrogance is more infuriating even, to customers, than lack of transparency.   .

  • Clinical data Transparency

    As the date for legislation approaches, each week brings more debate regarding the issue of clinical data transparency. ... Within the industry there appears to an appetite for increased transparency, with recognition of the scientific and patient

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics